Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Dendreon Corporation    

End-of-day quote. End-of-day quote  - 06/11
0.0325 USD   -4.41%
2015DJValeant Approved to Buy Dendreon Assets for $495 Million
2015 Drugmaker Valeant close to buying Salix - source
2015 VALEANT SECURES : Bloomberg
SummaryChartsNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector news 
Latest news on DENDREON CORPORATION
2015DJValeant Approved to Buy Dendreon Assets for $495 Million
2015 Drugmaker Valeant close to buying Salix - source
2015 VALEANT SECURES FINANCING FOR POTENT : Bloomberg
2015DJEnergy Future Fights for Control of its Bankruptcy -- Week Ahead
2015 DENDREON : Valeant to buy Dendreon's prostate cancer vaccine Provenge
2014 DENDREON CORPORATION : A New Combined Approach to Cancer Immunotherapy is Needed
2014 DENDREON CORPORATION : Bankruptcies, Breakouts, and Busts; What's Happening in B..
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014DJMARKET SNAPSHOT : U.S. Stocks Eke Out Monday Gains; S&P 500, Dow Hit Records
2014 DENDREON : Reaches Agreements on Terms of Financial Restructuring
2014 Feature - As music sales fall, sax player Kenny G turns to stockpicking
2014 DENDREON : Names W. Thomas Amick President and Chief Executive Officer
2014 DENDREON : Announces Leadership Transition
2014 DENDREON : Treatment with PROVENGE® (sipuleucel-T) Induces Antigen Spread Associ..
2014 DENDREON : Announces Presentation of PROVENGE® (sipuleucel-T) and DN24-02 Immuno..
2014 DENDREON : Announces First Quarter 2014 Results
2014DENDREON CORPORATION : quaterly earnings release
2014 DENDREON : to Host Conference Call on May 8 to Announce First Quarter Financial ..
2014 DENDREON : Immune Responses Enhanced and Sustained When PROVENGE® (sipuleucel-T)..
2014 Exclusive - Germany OKs Northwest Bio brain cancer drug, shares soar
2014 Dendreon shares jump on news of prostate drug's European launch
2014 DENDREON CORPORATION : Dendreon Announces Plans to Make PROVENGE® Commercially A..
2014 DENDREON CORPORATION : Dendreon Announces Plans to Make PROVENGE® Commercially A..
2014 DENDREON CORPORATION : Dendreon Announces Fourth Quarter and 2013 Year End Resul..
2014 DENDREON CORPORATION : SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP ..
2014 DENDREON CORPORATION : Dendreon Announces Webcast Presentation at Cowen and Comp..
2014 DENDREON CORPORATION : Dendreon to Host Conference Call on March 3 to Announce F..
2014 DENDREON CORPORATION : Dendreon Announces Presentation of PROVENGE® (sipuleucel-..
2014 DENDREON CORPORATION : Dendreon Announces Presentation of PROVENGE® (sipuleucel-..
2014 DENDREON CORPORATION : Dendreon Announces Preliminary Fourth Quarter 2013 Revenu..
2014 DENDREON CORPORATION : Dendreon Announces Change to Presentation Date and Time a..
2014 DENDREON CORPORATION : Dendreon Announces Webcast Presentation at J.P. Morgan He..
2013 DENDREON CORPORATION : Clinical Studies Updates, and Stock Price Movements - Res..
2013 DENDREON CORPORATION : Dendreon Announces Webcast Presentation at Deutsche Bank ..
2013DJD. E. SHAW & CO. LP 3Q 13F : Largest Eliminations -2-
2013DJD. E. SHAW & CO. LP 3Q 13F : Largest Eliminations
2013DJS.A.C. CAPITAL ADVISORS LP 3Q 13F : Largest Sales -2-
2013DJS.A.C. CAPITAL ADVISORS LP 3Q 13F : Largest Sales
2013DJFIDELITY MANAGEMENT & RESEARCH CO. 3 : -2-
2013DJFIDELITY MANAGEMENT & RESEARCH CO. 3 : Largest Eliminations
2013 DENDREON CORPORATION : Dendreon Announces Third Quarter 2013 Results
2013DENDREON CORPORATION : quaterly earnings release
2013 DENDREON CORPORATION : Five Star Equities Issues New Research Reports on DNDN, E..
2013DJDENDREON CORPORATION : Dendreon, Maker of Provenge, Seeking Buyer -Bloomberg
2013 DENDREON CORPORATION : Market Briefing: Emerging Growth NASDAQ Stocks in the New..
2013 DENDREON CORPORATION : Dendreon to Host Conference Call on November 12 to Announ..
2013 DENDREON CORPORATION : Announces Presentation of PROVENGE® (sipuleucel-T) Data a..
2013 DENDREON CORPORATION : Dendreon Announces Marketing Authorization for PROVENGE® ..
2013 DENDREON CORPORATION : Wall Street Fundamentals Releases New In-Depth Stock Repo..
2013 DENDREON CORPORATION : Wall Street Fundamentals Releases New In-Depth Stock Repo..
2013 DENDREON CORPORATION : Dendreon Announces Second Quarter 2013 Results
2013 DENDREON CORPORATION : Dendreon to Host Conference Call on August 8 to Announce ..
2013DJU.S. HOT STOCK FUTURES : Hot stocks to watch
2013 DENDREON CORPORATION : Dendreon Receives Positive Opinion for PROVENGE® in the E..
2013 DENDREON CORPORATION : Dendreon Announces Presentation of PROVENGE® (sipuleucel-..
2013 Analysis - A hard day to be a short-seller, one of many this year
2013 DENDREON CORPORATION : Dendreon Announces First Quarter 2013 Results
2013 DENDREON CORPORATION : StockCall Pre-Market Review on DNDN, SRPT, ACAD, CTIC, an..
2013 DENDREON CORPORATION : PROVENGE® (sipuleucel-T) Data Presented at An Annual Scie..
2013 DENDREON CORPORATION : Dendreon to Host Conference Call on May 9 to Announce Fir..
2013 DENDREON CORPORATION : Dendreon Announces Securities Class Action Settlement
2013 DENDREON CORPORATION : Dendreon Announces Webcast Presentation at ROTH Conferenc..
2013 DENDREON CORPORATION : Dendreon Announces Fourth Quarter and 2012 Year End Resul..
2013DENDREON CORPORATION : quaterly earnings release
2013DJGlaxo Research Chief Looks Ahead to Next Wave of New Medicines
2013 DENDREON CORPORATION : New PROVENGE® (sipuleucel-T) Data to Be Presented at 2013..
2013 DENDREON CORPORATION : Dendreon to Host Conference Call on February 25 to Announ..
2013 Wall Street ends flat as rally slows, earnings eyed
2013 DENDREON CORPORATION : Dendreon Announces Preliminary Fourth Quarter 2012 Revenu..
2012 DENDREON CORPORATION : Dendreon Sells New Jersey Immunotherapy Manufacturing Fac..
2012 DENDREON CORPORATION : Dendreon Announces Webcast Presentations at Upcoming Conf..
2012 DENDREON CORPORATION : Dendreon Appoints Lindsay Rocco to Lead Corporate Communi..
1  2  3  4Next
Advertisement
Chart DENDREON CORPORATION
Duration : Period :
Dendreon Corporation Technical Analysis Chart | US24823Q1076 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Managers
NameTitle
Craig R. Jalbert President, Secretary, Treasurer & Director
William Monteith Executive Vice President-Technical Operations
Andrew S. Sandler Chief Medical Officer & Executive Vice President
April Falcone Head-Corporate Communications
Silvio Pacheco Chief Customer Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DENDREON CORPORATION-55.48%0
INCYTE CORPORATION-14.06%17 522
CELLTRION, INC.--.--%11 533
LONZA GROUP AG12.32%10 064
QUINTILES TRANSNATIONA..15.89%9 472
SEATTLE GENETICS, INC.23.28%7 775
More Results